About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
European Journal of Nuclear Medicine and Molecular Imaging
›
Top Articles
European Journal of Nuclear Medicine and Molecular Imaging
Nuclear Medicine
,
Radiology
8.8
(top 1%)
Impact Factor
9.6
(top 1%)
extended IF
163
(top 2%)
H-Index
4.4K
authors
6.4K
papers
221.6K
citations
6.1K
citing journals
50.8K
citing authors
Most Cited Articles of European Journal of Nuclear Medicine and Molecular Imaging
Title
Year
Citations
FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0
2015
1.4K
FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0
2010
959
Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use
2000
754
The diagnostic value of PET/CT imaging with the (68)Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer
2015
745
Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET/CT for the diagnosis of recurrent prostate cancer
2014
681
PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions
2013
634
Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD
2005
626
Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2
2020
486
The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours
2013
462
Guidelines for radioiodine therapy of differentiated thyroid cancer
2008
445
Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study
2003
438
Concomitant expression of several peptide receptors in neuroendocrine tumours: molecular basis for in vivo multireceptor tumour targeting
2003
427
EANM/ESC procedural guidelines for myocardial perfusion imaging in nuclear cardiology
2005
405
Brown adipose tissue: a factor to consider in symmetrical tracer uptake in the neck and upper chest region
2002
403
Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0
2017
399
Biokinetics and imaging with the somatostatin receptor PET radioligand (68)Ga-DOTATOC: preliminary data
2001
398
Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours
2007
392
EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2
2009
377
Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer
1998
360
Detection of bone metastases in patients with lung cancer: 99mTc-MDP planar bone scintigraphy, 18F-fluoride PET or 18F-FDG PET/CT
2009
357
Myocardial perfusion scintigraphy: the evidence
2004
352
Diagnostic performance of Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients
2017
343
A gradient-based method for segmenting FDG-PET images: methodology and validation
2007
328
Quantifying tumour heterogeneity in 18F-FDG PET/CT imaging by texture analysis
2013
326
Nuclear imaging of neuroinflammation: a comprehensive review of [11C]PK11195 challengers
2008
324
0
1
2
next
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.